Tag: cannabinoid pharmaceutical R&D
AusCann raises A$33.4m via share placement
ASX-listed medical marijuana company AusCann has successfully raised A$33.4 million via a share placement to institutional and sophisticated investors from North America and Australia, including...
Featured Article
Automotive canopy and tray manufacturer manages 6,000 SKUs with self-implemented ERP
Australian automotive accessories manufacturer Trig Point self-implemented an ERP system in just three months and gained control over its unwieldy component inventory, product customizations, and production processes. “We wouldn’t be able to manage that without a system like this,” says Chris Wasylkiw, Production Engineer.
